Trastuzumab Active Not Recruiting Phase 1 Trials for Neoplasms, Breast Treatment

Active Not RecruitingTreatment1 IdentifierTitleDrugs
NCT00251433GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer
NCT03013881A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers
NCT00367471Combination Of Lapatinib With Carboplatin, Paclitaxel and Trastuzumab In Metastatic Breast Cancer.